| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |